BRPI0713331A2 - composição para a transfecção de ácido nucléico - Google Patents

composição para a transfecção de ácido nucléico Download PDF

Info

Publication number
BRPI0713331A2
BRPI0713331A2 BRPI0713331-6A BRPI0713331A BRPI0713331A2 BR PI0713331 A2 BRPI0713331 A2 BR PI0713331A2 BR PI0713331 A BRPI0713331 A BR PI0713331A BR PI0713331 A2 BRPI0713331 A2 BR PI0713331A2
Authority
BR
Brazil
Prior art keywords
nucleic acid
composition
acid transfection
cells
transfection
Prior art date
Application number
BRPI0713331-6A
Other languages
English (en)
Inventor
Kikuchi Hiroshi
Kobayashi Hideo
Hashimoto Kouichi
Iljima Ayako
Asano Daigo
Original Assignee
Hokkaido System Science Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido System Science Co., Ltd. filed Critical Hokkaido System Science Co., Ltd.
Publication of BRPI0713331A2 publication Critical patent/BRPI0713331A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

COMPOSIçãO PARA A TRANSFECçãO DE áCIDO NUCLéICO. Proporcionar uma composição para a transfecção de ácido nucléico, a qual exibe baixa citotoxicidade, a qual facilita uma transfecção de ácido nucléico nas células, e a qual aperfeiçoa a expressão do ácido nucléico nas células. A invenção proporciona uma composição para transfectar um ácido nucléico em uma célula, incluindo um composto representado pela fórmula (I) a seguir (onde cada um de R^1^e R^2^, que são idênticos um ao outro, ou diferentes um do outro, representa um grupo hidrocarboneto de C~12-22~ saturado ou insaturado; R^3^ representa um grupo alquila de C~1-6~ ou um grupo hidroxialquila de C~1-6~; m é um número inteiro de 1 a 10; e X representa um átomo de halogênio), e um fosfolipídio.
BRPI0713331-6A 2006-06-30 2007-06-29 composição para a transfecção de ácido nucléico BRPI0713331A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006182510 2006-06-30
JP2006-182510 2006-06-30
PCT/JP2007/000720 WO2008001505A1 (en) 2006-06-30 2007-06-29 Composition for nucleic-acid introduction

Publications (1)

Publication Number Publication Date
BRPI0713331A2 true BRPI0713331A2 (pt) 2012-03-13

Family

ID=38845280

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713331-6A BRPI0713331A2 (pt) 2006-06-30 2007-06-29 composição para a transfecção de ácido nucléico

Country Status (9)

Country Link
US (1) US8227248B2 (pt)
EP (1) EP2034019B1 (pt)
JP (1) JP5325576B2 (pt)
KR (1) KR101430773B1 (pt)
CN (1) CN101479384B (pt)
BR (1) BRPI0713331A2 (pt)
CA (1) CA2656228C (pt)
RU (1) RU2009103003A (pt)
WO (1) WO2008001505A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4481047A3 (en) * 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
US20120308642A1 (en) * 2011-05-27 2012-12-06 Xavier University Of Louisiana Inhibiting hepatitis c viral replication with sirna combinations
CN107043334B (zh) * 2011-06-08 2020-06-16 日东电工株式会社 用于定向药物输送和增强siRNA活性的化合物
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
US20240108545A1 (en) 2022-10-03 2024-04-04 West Pharmaceutical Services, Inc. Methods and adapters for mixing pharmaceutical complexes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2923296B2 (ja) * 1988-11-14 1999-07-26 株式会社ビタミン研究所 細胞への遺伝子導入法
JP2958076B2 (ja) 1990-08-27 1999-10-06 株式会社ビタミン研究所 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
JPH06200336A (ja) * 1992-09-01 1994-07-19 Mitsui Cyanamid Co コバルトとニッケルの分離方法
JPH09248182A (ja) * 1996-03-15 1997-09-22 Oyo Seikagaku Kenkyusho プラスミド包埋多重膜リポソーム
WO1998045463A1 (en) * 1997-04-07 1998-10-15 Daiichi Pharmaceutical Co., Ltd. Composition for gene introduction into cell
JP4601143B2 (ja) * 2000-06-13 2010-12-22 大塚製薬株式会社 新規酵素遺伝子およびその発現産物
US20040072769A1 (en) * 2002-09-16 2004-04-15 Yin James Qinwei Methods for design and selection of short double-stranded oligonucleotides, and compounds of gene drugs
AU2002953285A0 (en) * 2002-12-12 2003-01-02 Protech Research Pty Ltd Yeast treatment
JP2007520481A (ja) * 2004-01-15 2007-07-26 アルザ・コーポレーシヨン 治療薬を送達するためのリポソーム組成物
US7745651B2 (en) * 2004-06-07 2010-06-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods of use
GB0418172D0 (en) * 2004-08-13 2004-09-15 Ic Vec Ltd Vector
WO2006081171A1 (en) * 2005-01-24 2006-08-03 Amgen Inc. Humanized anti-amyloid antibody

Also Published As

Publication number Publication date
WO2008001505A1 (en) 2008-01-03
US20090239222A1 (en) 2009-09-24
CA2656228A1 (en) 2008-01-03
CA2656228C (en) 2016-02-09
RU2009103003A (ru) 2010-08-10
JPWO2008001505A1 (ja) 2009-11-26
US8227248B2 (en) 2012-07-24
EP2034019B1 (en) 2014-08-20
CN101479384A (zh) 2009-07-08
JP5325576B2 (ja) 2013-10-23
CN101479384B (zh) 2012-11-07
EP2034019A1 (en) 2009-03-11
KR20090034821A (ko) 2009-04-08
EP2034019A4 (en) 2010-12-01
KR101430773B1 (ko) 2014-08-18

Similar Documents

Publication Publication Date Title
BR112016002083A2 (pt) composto tetrazolinona e uso para o mesmo
BRPI0702269A (pt) alcanolamidas e uso do mesmo como aditivos de combustìvel
BR112012000968A8 (pt) Composto, composição e método para inibir uma fosfatidil inositol-3 cinase.
BR112013016595A2 (pt) inibidores de neprilisina
MX2010004109A (es) 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BR112015009806A2 (pt) composições adjuvantes aquosas
EA201190306A1 (ru) Улучшенная липидная композиция
BRPI0613429A2 (pt) inibidores de histona desacetilase
MX2022012676A (es) Compuestos y metodos para modular el empalme.
BR112018005307A2 (pt) aditivo para conferir baixo acúmulo de calor a um componente de borracha
BR112015000579A2 (pt) tioxantonas polimerizáveis
BR0112081A (pt) Composição de óleo vegetal biodegradável
BR112014027859A2 (pt) composição detergente para lavagem de roupas compreedendo uma partícula que tem um agente de tonalização e argila
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR112015026441A2 (pt) derivados de fulereno aperfeiçoados e materiais, métodos e dispositivos relacionados
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
BR112014010050A8 (pt) derivados de aminoácido funcionalizados na terminação n capazes de formar microesferas de encapsulação de fármaco
BR112013003424A2 (pt) composições de remoção carboxiéster cetal, métodos de fabricação, e usos dos mesmos
CR10213A (es) Moduladores de la proteína quinasa aurora
BR112018076686A2 (pt) composição para a remoção de composto que contém enxofre
BR112014019903A8 (pt) Uso de um copolímero e processo para inibição e/ou dispersão de escamas de sulfeto
BR112014031168A2 (pt) composições cosméticas compreendendo agentes promotores da biossíntese de hialuronana
BR112012023282A2 (pt) processo para separar silicatos e carbonatos de metal alcalino terroso, produtos que contém carbonato de metal alcalino terroso e que contém silicato, e, uso os produtos
BR112013031103A2 (pt) síntese de derivados de 7-acetileno quinonametídeo e sua aplicação como retardadores da polimerização de vinilícos
MX2010003230A (es) Metodos para la sintesis de ciertos compuestos de acido hidroxamico.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL